NCT04903366View on ClinicalTrials.gov

Absorption and Safety of Topical Timolol to Treat Chronic Wounds

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

March 9, 2018

Study Completion Date

January 14, 2020

Conditions
Glaucoma, Open-AngleChronic Wounds
Interventions
DRUG

Timolol Maleate

timolol maleate 0.5% gel-forming solution

Trial Locations (1)

95655

VA Northern California Health Care System, Mather

All Listed Sponsors
lead

VA Northern California Health Care System

FED

NCT04903366 - Absorption and Safety of Topical Timolol to Treat Chronic Wounds | Biotech Hunter | Biotech Hunter